2 results about "Angina" patented technology

The present invention relates to the use of bacterial compositions having an arginine deiminase activity (inhibition of nitric oxide synthase by conversion of L-arginine to L-citrulline) of 1-1,000 μmol L-citrulline / h / g composition and a sphingomyelinase (ceramide generation) activity of 0.01-1.000 nmoles ceramides / h / g composition in the treatment and / or prophylaxis of airway diseases caused by viruses such as influenza viruses, coronaviruses, as SARS-CoV, MERS-CoV and SARS-CoV-2, avian viruses, respiratory syncytial virus (VRS), rhinoviruses, pneumoviruses, or respiratory failure induced or aggravated by viral infections, angina pectoris, pulmonary heart, respiratory distress, pulmonary edema, neonatal asphyxia, myocardial infarction, heart failure, respiratory failure Pickwick syndrome, pulmonary hypertension, pneumonia or even cystic fibrosis (CF) aggravated by viral infections.

The application discloses a quality detection method for active ingredients of a traditional Chinese medicine compound for dredging blood vessels and reducing blood sugar by using UPLC-Q / TOF-MS, and has the advantages of comprehensive detection components, high sensitivity and simple operation. 186 chemical components are identified, including 45 terpene components, 41 glycoside components, 19 organic acid components, 18 flavone components, 10 alkaloid components, 6 sugar components and 47 other components. The detection method can be applied to internal quality control standards, chemical component identification and intermediate component detection of the traditional Chinese medicine compound for dredging blood vessels and reducing blood sugar.